Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acetic Acid-Enhanced Endoscopy for Gastric Intestinal Metaplasia Diagnosis
NCT02806115Phase 1Unknown
- Sponsor
- Shandong University
- Start
- Jun 2016
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of acetic acid in gastric intestinal metaplasia (IM), sponsored by Shandong University. Primary endpoints: Accuracy of severe whitening for diagnosing gastric intestinal metaplasia at 6 months and Accuracy of delayed fading for diagnosing gastric intestinal metaplasia at 6 months. Status: unknown.
02
Drugs
acetic acid
03
Conditions
gastric intestinal metaplasia (IM)
Beyond the preview
Go deeper on NCT02806115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02806115.